| |
|
|
|
BioCryst Pharmaceuticals Inc.  
|
|
7.33 -0.24 (-0.03%) |
05-17 16:00 |
|
Open: |
7.45 |
Pre close: |
7.57 |
Target:
|
9.61
|
|
High: |
7.54 |
Low: |
7.16 |
Resistance:
|
8.23
8.89
|
|
Volume: |
936,753 |
Market Cap: |
809M |
Support:
|
7.16
5.96
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.65
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
7.76 |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
8.35  |
Stochastic Oscillator |
%K(14,3):
|
45.12 |
|
MA(250): |
7.53 |
%D(3): |
54.79 |
|
Average Volume(K) |
3-Month: |
89745
|
52-Week |
High:
|
9.95 |
|
10-Days: |
102750 |
Low: |
5.34 |
|
RSI |
RSI(14):
|
41.03 |
Change(%): |
24.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.980 |
Return on Equity (ttm) |
30.2 |
Shares Out. (M) |
110.27 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-75.1 |
Shares Float (M) |
106.20 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
-0.32 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-29.8 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-0.900 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
17.490 |
EBITDA (p.s.) |
0.000 |
P/E |
-7.48 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.42 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-92.56 |
P/S |
4041395456.00 |
|
Operating Margin |
-402.94 |
Levered Free Cash Flow
(M) |
-49.84 |
P/CF |
-8.73 |
|
|
|
|
|
|
